Milestone
-
2017
2017.08 Heron Neutron Medical Corp. Established -
2019
2019.08 Signed a Memorandum of Cooperation with CMU -
2020
2020.08 Settled in Hsinchu Biomedical Science Park -
2021
2021.04 Purchase Accelerator2021.11 Built the AB-BNCT site in China Medical University -
2022
2022.01 Obtained High-Intensity Radiation Facility Install License2022.05 Obtained Medical Device Manufacturing Selling License2022.12 Top Out the First AB-BNCT Treatment Center in CMU, Taiwan2022.12 Obtained The Medicine Selling License2022.12 Won the 19th National Innovation Award in 2022 -
2023
2023.05 Completion AB-BNCT treatment Center and obtained license2023.09 20th Taipei Biotech Awards Innovation Silver Award2023.09 Obtained the Operation Permit of AB-BNCT Site In CMU2023.12 The Hsinchu Science Park Innovation Award -
2024
2024.02 Obtain High-Intensity Radiation Facility Operation Certificate2024.05 HERON BNCT Center Inaugurated2024.06 Obtained Generate Ionizing Radiation Device License2024.06 Obtained Domestic Medical Device Manufacture License2024.07 Obtain AB-BNCT Medical Device License, First In Taiwan2024.10 Mr. Archie Hwang Donated Heron AB-BNCT Device to NYCU2024.11 Heron and TVGH Launch the First Clinical Trial of AB-BNCT2024.11 Heron officially traded on the Emerging Stock Board2024.11 "Bennu" Neutron Irradiation System obtain SNQ Mark2024.11 2024 National Innovation and Advancement Award -
2025
2025.06 Completed the First AB-BNCT Trial for rHNC2025.08 Officially obtained ISO 13485 certification2025.09 HNMC (Ticker: 7799) listed on the TWSE2025.12 Promoting the Collaborative Initiative for Southeast Asia's First AB-BNCT Research Center -
2026
2026.01 HERON Partners with NYCU and Chu Ming Foundation to Establish an Advanced BNCT Imaging Center2026.01 Collaboration initiated with Siemens Healthineers on AI-enabled AB-BNCT platform2026.03 HERON Partners with PELL Bio-Med to Advance Research on Combined AB-BNCT and Immunotherapy Treatments2026.05 HERON Submits AB-BNCT Registration to Singapore HSA2026.05 HERON and TVGH Explore BNCT Neoadjuvant Therapy for Head and Neck Cancer
